15
staff
Raymond Puerini
Raymond Puerini is an associate director at FasterCures, a center of the Milken Institute.
staff
Mark Williams
Mark Williams is an associate director at FasterCures, a center of the Milken Institute.
staff
Anita Nosratieh
Anita Nosratieh is an Associate Director at FasterCures. Her experience spans preclinical researc
h, clinical trials and regulatory affairs. Prior to FasterCures, she was a Managing Consultant at Navigant Inc.
+ Read More
staff
Jeff Valliere
Jeff Valliere is the Chief of Staff and Head of Strategy at the Milken Institute, overseeing the
development of fully integrated, strategic initiatives that support the mission, vision, and values of the Milken Institute. Previously, Jeff was the Head o
+ Read More
staff
Amy Gilbert Fehir
Amy Fehir is a Senior Director of Business and Program Development at the Milken Institute.
article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
+ Read More
article
Health policy leader Esther Krofah named executive director of FasterCures
WASHINGTON, March 4, 2020 – Esther Krofah, a respected leader in biomedical research, development, a
nd public policy, has been named executive director of FasterCures, the Milken Institute center devoted to accelerating access to life-s
+ Read More
report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering 
;the market and can identify multiple cancers early and simultaneously.
+ Read More
report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
+ Read More
article
Milken Institute launches COVID-19 vaccine and treatment tracker
Publicly available resource monitors the development of therapies to treat and prevent disease
article
Milken Institute COVID-19 tracker update identifies dozens of new treatments and vaccines in development
Two potential vaccines moving to clinical trial stage in addition to WHO’s global SOLIDARITY trial